B7-33 Peptide – Advanced RXFP1 Research Compound

B7-33 is a synthetic peptide derived from relaxin and is widely recognized in preclinical research for its selective signaling properties. Unlike conventional receptor agonists, B7-33 has attracted scientific interest because of its ability to produce pathway-specific intracellular responses through the RXFP1 receptor.

This innovative research peptide is being investigated for receptor modulation, kinase signaling, and structure-function relationships in engineered peptides. Its selective signaling profile makes it a valuable tool for researchers studying GPCR pathways and intracellular communication mechanisms.

Key Features

• High-quality B7-33 synthetic peptide
• Research-grade purity for laboratory applications
• Selective RXFP1 receptor agonist
• Investigated for ERK1/2 pathway activation
• Suitable for GPCR signaling research
• Third-party tested for quality and identity
• Certificate of Analysis (COA) available
• Intended strictly for research purposes

Proposed Mechanism of Action

Preclinical studies suggest that B7-33 interacts with the Relaxin Family Peptide Receptor 1 (RXFP1) in a highly selective manner. Unlike native relaxin peptides, B7-33 appears to favor specific intracellular pathways while minimizing excessive second messenger activity.

Research indicates that B7-33 may:

• Modulate ERK1/2 kinase signaling pathways
• Support pathway-restricted receptor activation
• Promote selective intracellular responses
• Reduce broad cAMP amplification compared to full agonists
• Serve as a model compound for receptor signaling studies

This unique signaling behavior makes B7-33 particularly valuable for understanding controlled receptor activation and biased agonism.

Research Applications of B7-33

RXFP1 Receptor Studies

Scientists utilize B7-33 to investigate selective activation of the RXFP1 receptor and analyze downstream signaling mechanisms involved in peptide-mediated cellular communication.

GPCR Signaling Research

B7-33 serves as an important tool for studying G protein-coupled receptor (GPCR) signaling bias and understanding how individual receptors generate distinct intracellular responses.

ERK Pathway Investigation

Researchers employ this peptide to map ERK-related signaling cascades and evaluate kinase activation under controlled experimental conditions.

Structure-Function Analysis

B7-33 is frequently used as a reference compound for exploring engineered peptide design and understanding structure-function relationships among synthetic peptides.

Pathway-Specific Modulation Studies

Preclinical models utilize B7-33 to examine selective receptor modulation strategies and controlled intracellular signaling responses.

Why Choose PureRawz B7-33?

PureRawz is recognized for supplying premium-quality research compounds backed by rigorous testing and quality assurance. Every batch of B7-33 undergoes comprehensive purity and identity verification to ensure consistency and reliability.

At nexacore.pk, customers throughout Pakistan can access authentic PureRawz peptides, SARMs, nootropics, and performance-enhancing research compounds. We are committed to delivering trusted products with reliable customer support and fast nationwide shipping.

Product Specifications

• Product Name: B7-33 Peptide
• Category: Synthetic Peptide
• Target Receptor: RXFP1
• Research Focus: GPCR Signaling and ERK1/2 Pathways
• Classification: Research Use Only (RUO)
• Purity: High-Purity Research Grade
• Testing: First and Third-Party Verified
• Certificate of Analysis: Included
• Application: Laboratory and Experimental Research

Disclaimer

B7-33 is intended strictly for laboratory and scientific research purposes only. This compound is not approved for human or veterinary use. Researchers should comply with all applicable guidelines and conduct independent investigations before use.